nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—L-DOPA—Melphalan—peripheral nervous system neoplasm	0.377	1	CrCrCtD
Dopamine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.193	0.453	CbGbCtD
Dopamine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0575	0.135	CbGbCtD
Dopamine—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.057	0.134	CbGbCtD
Dopamine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0315	0.074	CbGbCtD
Dopamine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0241	0.0566	CbGbCtD
Dopamine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0202	0.0474	CbGbCtD
Dopamine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0192	0.0452	CbGbCtD
Dopamine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00942	0.0221	CbGbCtD
Dopamine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00864	0.0203	CbGbCtD
Dopamine—DBH—cranial nerve—peripheral nervous system neoplasm	0.00579	0.0908	CbGeAlD
Dopamine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00529	0.0124	CbGbCtD
Dopamine—Prolonged menses—Vincristine—peripheral nervous system neoplasm	0.00426	0.0957	CcSEcCtD
Dopamine—POU5F1—cerebellum—peripheral nervous system neoplasm	0.00332	0.052	CbGeAlD
Dopamine—DBH—nerve—peripheral nervous system neoplasm	0.00297	0.0465	CbGeAlD
Dopamine—DBH—ganglion—peripheral nervous system neoplasm	0.00293	0.0459	CbGeAlD
Dopamine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00279	0.0437	CbGeAlD
Dopamine—DRD5—ganglion—peripheral nervous system neoplasm	0.00225	0.0353	CbGeAlD
Dopamine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00213	0.0333	CbGeAlD
Dopamine—HTR7—pons—peripheral nervous system neoplasm	0.0021	0.0329	CbGeAlD
Dopamine—DRD1—nerve—peripheral nervous system neoplasm	0.00174	0.0273	CbGeAlD
Dopamine—Cyanosis—Tretinoin—peripheral nervous system neoplasm	0.00173	0.0388	CcSEcCtD
Dopamine—Cyanosis—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.0388	CcSEcCtD
Dopamine—DRD1—ganglion—peripheral nervous system neoplasm	0.00172	0.027	CbGeAlD
Dopamine—Azotaemia—Vincristine—peripheral nervous system neoplasm	0.00168	0.0377	CcSEcCtD
Dopamine—COMT—ganglion—peripheral nervous system neoplasm	0.00155	0.0243	CbGeAlD
Dopamine—Extravasation—Topotecan—peripheral nervous system neoplasm	0.00141	0.0317	CcSEcCtD
Dopamine—SLC6A3—nerve—peripheral nervous system neoplasm	0.0014	0.022	CbGeAlD
Dopamine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00138	0.0217	CbGeAlD
Dopamine—Extravasation—Melphalan—peripheral nervous system neoplasm	0.00138	0.0311	CcSEcCtD
Dopamine—SLC22A1—ganglion—peripheral nervous system neoplasm	0.00136	0.0214	CbGeAlD
Dopamine—Cyanosis—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.0294	CcSEcCtD
Dopamine—SLC22A3—tongue—peripheral nervous system neoplasm	0.00129	0.0202	CbGeAlD
Dopamine—DBH—brainstem—peripheral nervous system neoplasm	0.00127	0.02	CbGeAlD
Dopamine—Necrosis—Dactinomycin—peripheral nervous system neoplasm	0.00127	0.0286	CcSEcCtD
Dopamine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00127	0.0199	CbGeAlD
Dopamine—MAOB—nerve—peripheral nervous system neoplasm	0.00122	0.0191	CbGeAlD
Dopamine—Menorrhagia—Vincristine—peripheral nervous system neoplasm	0.00121	0.0271	CcSEcCtD
Dopamine—MAOB—ganglion—peripheral nervous system neoplasm	0.00121	0.0189	CbGeAlD
Dopamine—Extravasation—Dactinomycin—peripheral nervous system neoplasm	0.00115	0.0257	CcSEcCtD
Dopamine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00113	0.0177	CbGeAlD
Dopamine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00113	0.0176	CbGeAlD
Dopamine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00112	0.0175	CbGeAlD
Dopamine—HTR7—nerve—peripheral nervous system neoplasm	0.00109	0.0171	CbGeAlD
Dopamine—HTR7—ganglion—peripheral nervous system neoplasm	0.00108	0.0169	CbGeAlD
Dopamine—MAOA—nerve—peripheral nervous system neoplasm	0.00104	0.0163	CbGeAlD
Dopamine—DRD2—nerve—peripheral nervous system neoplasm	0.00103	0.0161	CbGeAlD
Dopamine—MAOA—ganglion—peripheral nervous system neoplasm	0.00103	0.0161	CbGeAlD
Dopamine—Extravasation—Vincristine—peripheral nervous system neoplasm	0.00102	0.023	CcSEcCtD
Dopamine—Cyanosis—Etoposide—peripheral nervous system neoplasm	0.00102	0.023	CcSEcCtD
Dopamine—DRD2—ganglion—peripheral nervous system neoplasm	0.00102	0.0159	CbGeAlD
Dopamine—Necrosis—Cisplatin—peripheral nervous system neoplasm	0.00101	0.0226	CcSEcCtD
Dopamine—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.000948	0.0149	CbGeAlD
Dopamine—Atrial fibrillation—Melphalan—peripheral nervous system neoplasm	0.000924	0.0208	CcSEcCtD
Dopamine—Necrosis—Etoposide—peripheral nervous system neoplasm	0.000921	0.0207	CcSEcCtD
Dopamine—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.000905	0.0203	CcSEcCtD
Dopamine—Extravasation—Etoposide—peripheral nervous system neoplasm	0.000829	0.0186	CcSEcCtD
Dopamine—COMT—trigeminal ganglion—peripheral nervous system neoplasm	0.000761	0.0119	CbGeAlD
Dopamine—DRD1—brainstem—peripheral nervous system neoplasm	0.000749	0.0117	CbGeAlD
Dopamine—COMT—brainstem—peripheral nervous system neoplasm	0.000674	0.0106	CbGeAlD
Dopamine—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	0.00064	0.01	CbGeAlD
Dopamine—DBH—cerebellum—peripheral nervous system neoplasm	0.000628	0.00985	CbGeAlD
Dopamine—SLC22A3—parotid gland—peripheral nervous system neoplasm	0.000604	0.00946	CbGeAlD
Dopamine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.000602	0.00943	CbGeAlD
Dopamine—MAOB—trigeminal ganglion—peripheral nervous system neoplasm	0.000592	0.00928	CbGeAlD
Dopamine—MAOB—parotid gland—peripheral nervous system neoplasm	0.000559	0.00875	CbGeAlD
Dopamine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000551	0.00864	CbGeAlD
Dopamine—Ventricular arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000548	0.0123	CcSEcCtD
Dopamine—MAOB—brainstem—peripheral nervous system neoplasm	0.000524	0.00821	CbGeAlD
Dopamine—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.000516	0.0116	CcSEcCtD
Dopamine—Ventricular arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.0114	CcSEcCtD
Dopamine—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.000505	0.00792	CbGeAlD
Dopamine—HTR1A—brainstem—peripheral nervous system neoplasm	0.00049	0.00767	CbGeAlD
Dopamine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000485	0.00761	CbGeAlD
Dopamine—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.0107	CcSEcCtD
Dopamine—MAOA—parotid gland—peripheral nervous system neoplasm	0.000477	0.00747	CbGeAlD
Dopamine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000472	0.0106	CcSEcCtD
Dopamine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000472	0.0106	CcSEcCtD
Dopamine—HTR7—brainstem—peripheral nervous system neoplasm	0.000468	0.00733	CbGeAlD
Dopamine—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	0.000465	0.00729	CbGeAlD
Dopamine—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.000465	0.0104	CcSEcCtD
Dopamine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000461	0.0104	CcSEcCtD
Dopamine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000461	0.0104	CcSEcCtD
Dopamine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000453	0.0102	CcSEcCtD
Dopamine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000453	0.0102	CcSEcCtD
Dopamine—MAOA—brainstem—peripheral nervous system neoplasm	0.000447	0.00701	CbGeAlD
Dopamine—DRD2—brainstem—peripheral nervous system neoplasm	0.000442	0.00693	CbGeAlD
Dopamine—SLC22A5—parotid gland—peripheral nervous system neoplasm	0.000439	0.00688	CbGeAlD
Dopamine—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00966	CcSEcCtD
Dopamine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000426	0.00957	CcSEcCtD
Dopamine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000426	0.00957	CcSEcCtD
Dopamine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00042	0.00944	CcSEcCtD
Dopamine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000403	0.00907	CcSEcCtD
Dopamine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000392	0.00881	CcSEcCtD
Dopamine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000389	0.00874	CcSEcCtD
Dopamine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000389	0.00874	CcSEcCtD
Dopamine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000384	0.00862	CcSEcCtD
Dopamine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.00804	CcSEcCtD
Dopamine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.00786	CcSEcCtD
Dopamine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000344	0.00772	CcSEcCtD
Dopamine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000337	0.00757	CcSEcCtD
Dopamine—COMT—cerebellum—peripheral nervous system neoplasm	0.000332	0.00521	CbGeAlD
Dopamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00725	CcSEcCtD
Dopamine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000297	0.00465	CbGeAlD
Dopamine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.00662	CcSEcCtD
Dopamine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000293	0.00658	CcSEcCtD
Dopamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00028	0.00628	CcSEcCtD
Dopamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00623	CcSEcCtD
Dopamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00623	CcSEcCtD
Dopamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000275	0.00619	CcSEcCtD
Dopamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000275	0.00618	CcSEcCtD
Dopamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000274	0.00615	CcSEcCtD
Dopamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000273	0.00614	CcSEcCtD
Dopamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000273	0.00614	CcSEcCtD
Dopamine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000273	0.00613	CcSEcCtD
Dopamine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000266	0.00417	CbGeAlD
Dopamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000261	0.00587	CcSEcCtD
Dopamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000259	0.00582	CcSEcCtD
Dopamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000259	0.00582	CcSEcCtD
Dopamine—MAOB—cerebellum—peripheral nervous system neoplasm	0.000258	0.00405	CbGeAlD
Dopamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000256	0.00575	CcSEcCtD
Dopamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000252	0.00566	CcSEcCtD
Dopamine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000251	0.00564	CcSEcCtD
Dopamine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000248	0.00557	CcSEcCtD
Dopamine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000241	0.00378	CbGeAlD
Dopamine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000231	0.00361	CbGeAlD
Dopamine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00023	0.00517	CcSEcCtD
Dopamine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00515	CcSEcCtD
Dopamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000227	0.00509	CcSEcCtD
Dopamine—MAOA—cerebellum—peripheral nervous system neoplasm	0.00022	0.00346	CbGeAlD
Dopamine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000218	0.00342	CbGeAlD
Dopamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000212	0.00476	CcSEcCtD
Dopamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00472	CcSEcCtD
Dopamine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000207	0.00466	CcSEcCtD
Dopamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.00465	CcSEcCtD
Dopamine—SLC22A5—cerebellum—peripheral nervous system neoplasm	0.000203	0.00318	CbGeAlD
Dopamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000202	0.00455	CcSEcCtD
Dopamine—Headache—Vincristine—peripheral nervous system neoplasm	0.0002	0.00448	CcSEcCtD
Dopamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.00441	CcSEcCtD
Dopamine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00431	CcSEcCtD
Dopamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000189	0.00425	CcSEcCtD
Dopamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00402	CcSEcCtD
Dopamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000167	0.00376	CcSEcCtD
Dopamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000164	0.00369	CcSEcCtD
Dopamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000162	0.00363	CcSEcCtD
Dopamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00352	CcSEcCtD
Dopamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000153	0.00344	CcSEcCtD
Dopamine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00344	CcSEcCtD
Dopamine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00338	CcSEcCtD
Dopamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00326	CcSEcCtD
Dopamine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00318	CcSEcCtD
Dopamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00317	CcSEcCtD
Dopamine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00313	CcSEcCtD
Dopamine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000131	0.00205	CbGeAlD
Dopamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00293	CcSEcCtD
Dopamine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000129	0.0029	CcSEcCtD
Dopamine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00268	CcSEcCtD
Dopamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.00207	CcSEcCtD
Dopamine—Headache—Epirubicin—peripheral nervous system neoplasm	9.06e-05	0.00204	CcSEcCtD
Dopamine—Nausea—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.00193	CcSEcCtD
Dopamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.00191	CcSEcCtD
Dopamine—Headache—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.00188	CcSEcCtD
Dopamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.00179	CcSEcCtD
Dopamine—DRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.53e-05	0.000285	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.53e-05	0.000284	CbGpPWpGaD
Dopamine—MAOB—Metabolism—GNAS—peripheral nervous system neoplasm	2.52e-05	0.000284	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.52e-05	0.000283	CbGpPWpGaD
Dopamine—MAOA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.51e-05	0.000282	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.51e-05	0.000282	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.5e-05	0.000281	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.49e-05	0.00028	CbGpPWpGaD
Dopamine—MAOB—Metabolism—ABCB1—peripheral nervous system neoplasm	2.48e-05	0.000278	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.46e-05	0.000277	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ENO2—peripheral nervous system neoplasm	2.44e-05	0.000275	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.44e-05	0.000274	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.43e-05	0.000273	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.41e-05	0.000271	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.41e-05	0.000271	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.41e-05	0.000271	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.4e-05	0.00027	CbGpPWpGaD
Dopamine—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.33e-05	0.000262	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.33e-05	0.000262	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.32e-05	0.000261	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.3e-05	0.000258	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.28e-05	0.000256	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.27e-05	0.000255	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.25e-05	0.000253	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.22e-05	0.000249	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.19e-05	0.000247	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.19e-05	0.000247	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.19e-05	0.000246	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.18e-05	0.000245	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.17e-05	0.000244	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.15e-05	0.000241	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	2.14e-05	0.00024	CbGpPWpGaD
Dopamine—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.12e-05	0.000239	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.11e-05	0.000237	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.1e-05	0.000236	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.1e-05	0.000236	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.1e-05	0.000236	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.07e-05	0.000232	CbGpPWpGaD
Dopamine—MAOA—Metabolism—BCHE—peripheral nervous system neoplasm	2.06e-05	0.000232	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.06e-05	0.000231	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.03e-05	0.000228	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2e-05	0.000225	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2e-05	0.000225	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.99e-05	0.000224	CbGpPWpGaD
Dopamine—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.98e-05	0.000222	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000222	CbGpPWpGaD
Dopamine—MAOA—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.97e-05	0.000221	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.95e-05	0.000219	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.94e-05	0.000219	CbGpPWpGaD
Dopamine—MAOA—Metabolism—TH—peripheral nervous system neoplasm	1.94e-05	0.000218	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.93e-05	0.000216	CbGpPWpGaD
Dopamine—MAOA—Neuronal System—HRAS—peripheral nervous system neoplasm	1.92e-05	0.000216	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.91e-05	0.000215	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.91e-05	0.000215	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.91e-05	0.000214	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.91e-05	0.000214	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.84e-05	0.000207	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.83e-05	0.000206	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.79e-05	0.000201	CbGpPWpGaD
Dopamine—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	1.79e-05	0.000201	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.76e-05	0.000198	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.76e-05	0.000198	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.76e-05	0.000197	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.75e-05	0.000197	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.75e-05	0.000196	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.74e-05	0.000196	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.74e-05	0.000195	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.73e-05	0.000194	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.71e-05	0.000192	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.71e-05	0.000192	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.68e-05	0.000189	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.67e-05	0.000188	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.67e-05	0.000188	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.67e-05	0.000187	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.66e-05	0.000187	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.66e-05	0.000186	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	1.64e-05	0.000184	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.63e-05	0.000183	CbGpPWpGaD
Dopamine—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.63e-05	0.000183	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.62e-05	0.000182	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.61e-05	0.000181	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.59e-05	0.000178	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GNAS—peripheral nervous system neoplasm	1.58e-05	0.000178	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.57e-05	0.000177	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ABCB1—peripheral nervous system neoplasm	1.55e-05	0.000175	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.55e-05	0.000174	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.54e-05	0.000173	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	1.53e-05	0.000172	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.52e-05	0.000171	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.52e-05	0.000171	CbGpPWpGaD
Dopamine—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.52e-05	0.00017	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.51e-05	0.000169	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.5e-05	0.000168	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.49e-05	0.000167	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.48e-05	0.000166	CbGpPWpGaD
Dopamine—DBH—Metabolism—AKT1—peripheral nervous system neoplasm	1.46e-05	0.000164	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.45e-05	0.000163	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.43e-05	0.00016	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.43e-05	0.00016	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.41e-05	0.000158	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.39e-05	0.000157	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.38e-05	0.000156	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.37e-05	0.000154	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.37e-05	0.000154	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.35e-05	0.000151	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.34e-05	0.000151	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000149	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.32e-05	0.000149	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.31e-05	0.000148	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000147	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000145	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.29e-05	0.000145	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.28e-05	0.000144	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.25e-05	0.00014	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.23e-05	0.000138	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.23e-05	0.000138	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.18e-05	0.000132	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.16e-05	0.000131	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	1.16e-05	0.00013	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.13e-05	0.000127	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000127	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.000122	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.08e-05	0.000121	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.07e-05	0.000121	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.06e-05	0.00012	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.000119	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.05e-05	0.000119	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.03e-05	0.000116	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.02e-05	0.000115	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.01e-05	0.000114	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.92e-06	0.000111	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.89e-06	0.000111	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.82e-06	0.00011	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	9.77e-06	0.00011	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.32e-06	0.000105	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.26e-06	0.000104	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	9.18e-06	0.000103	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.14e-06	0.000103	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.1e-06	0.000102	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	9.01e-06	0.000101	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9e-06	0.000101	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	8.99e-06	0.000101	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.98e-06	0.000101	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	8.91e-06	0.0001	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.57e-06	9.64e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.5e-06	9.55e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	8.45e-06	9.5e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	8.37e-06	9.41e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.35e-06	9.38e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.33e-06	9.36e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.23e-06	9.26e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.18e-06	9.2e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.99e-06	8.98e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.96e-06	8.95e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.86e-06	8.84e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.82e-06	8.8e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.67e-06	8.62e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.65e-06	8.59e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	7.61e-06	8.56e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.57e-06	8.51e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.53e-06	8.46e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	7.5e-06	8.43e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	7.36e-06	8.27e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.32e-06	8.23e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.26e-06	8.16e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.25e-06	8.15e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.19e-06	8.08e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—AKT1—peripheral nervous system neoplasm	7.19e-06	8.08e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	7.16e-06	8.04e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.1e-06	7.98e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.99e-06	7.86e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.94e-06	7.8e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	6.9e-06	7.75e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.87e-06	7.72e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	6.84e-06	7.69e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—AKT1—peripheral nervous system neoplasm	6.81e-06	7.66e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.78e-06	7.62e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.77e-06	7.61e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	6.71e-06	7.54e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.69e-06	7.51e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.65e-06	7.47e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.59e-06	7.41e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.53e-06	7.34e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.5e-06	7.31e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.47e-06	7.27e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.44e-06	7.24e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.35e-06	7.14e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.3e-06	7.08e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.18e-06	6.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.09e-06	6.85e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.08e-06	6.83e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.02e-06	6.77e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.98e-06	6.73e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.92e-06	6.66e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.91e-06	6.65e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.9e-06	6.64e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.87e-06	6.6e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	5.84e-06	6.57e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.83e-06	6.55e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	5.77e-06	6.48e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.73e-06	6.44e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.67e-06	6.37e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.66e-06	6.36e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.61e-06	6.31e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.47e-06	6.15e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.43e-06	6.1e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.4e-06	6.07e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.38e-06	6.05e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.32e-06	5.98e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.14e-06	5.78e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.12e-06	5.75e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.1e-06	5.73e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.03e-06	5.65e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.97e-06	5.59e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.93e-06	5.54e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.92e-06	5.53e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.86e-06	5.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.7e-06	5.29e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.65e-06	5.23e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.64e-06	5.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.58e-06	5.15e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.52e-06	5.08e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.45e-06	5e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.38e-06	4.93e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—peripheral nervous system neoplasm	4.28e-06	4.81e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.19e-06	4.7e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.13e-06	4.64e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.13e-06	4.64e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.1e-06	4.61e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4e-06	4.5e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.95e-06	4.44e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.93e-06	4.41e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.85e-06	4.33e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.76e-06	4.23e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.62e-06	4.06e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.6e-06	4.05e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.6e-06	4.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.53e-06	3.97e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.49e-06	3.92e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.44e-06	3.87e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.37e-06	3.79e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.18e-06	3.57e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.16e-06	3.55e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.04e-06	3.42e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.02e-06	3.4e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.67e-06	3e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.02e-06	2.27e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.86e-06	2.09e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.85e-06	2.07e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.58e-06	1.77e-05	CbGpPWpGaD
